echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Domestic giants are gnawing at the lack of core technology for high-end medical devices

    Domestic giants are gnawing at the lack of core technology for high-end medical devices

    • Last Update: 2021-02-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Domestic high-end medical device market into the development period, but the core technology and services are still the development of enterprises pain point. Beijing Business Daily reporter survey found that including Nesod Medical, Sanoway Sheng, Guang medicine Baiyunshan and other enterprises to accelerate access to the high-end medical equipment market. For a long time, more than 80% of the market for high-end medical devices has been monopolized by multinational companies. Despite the rise of domestic high-end medical manufacturers with independent research and development capabilities, it is inevitable that core components are still being purchased abroad and assembled at home.enterprises have laid out
    the domestic high-end medical device market for a long time by foreign monopoly situation began to change. Zhao Zhilin, chairman of the China Medical Equipment Association, said that China's medical equipment industry has entered a golden age of development, the development of the industry will usher in earth-shaking changes, it is expected that by 2020, the size of the medical equipment market will exceed 800 billion yuan. The huge market size attracts many domestic enterprises to lay out high-end medical devices.
    , Sanoway Technology (Beijing) Co., Ltd. (hereinafter referred to as "Sanoway" ) officially launched its own research and development of the "fine wide-angle" series CT. It is understood that the launch of the product in 76 cm large aperture, 20 lines on the spatial resolution to achieve a breakthrough. Data show that Sanoway was founded in 2012, has been Zhongguancun high-tech enterprises and state-level high-tech enterprises double certification.
    fact, it's not just Sanowissa that is targeting high-end medical devices. In July, Dongso soft medical completed the equity delivery, opening the countdown to the listing. According to Wu Shaojie, CEO of Dongso soft medical, with the gradual development of the high-end market, with CT and other imaging equipment research and development and manufacturing as the main business of Dongsooi Medical will be listed on the agenda. At the same time, Wu Shaojie revealed that in the future, Dongso Soft Medical will increase investment in high-end medical device research and development.
    also interested in high-end equipment in the field of medical devices mainly wholesale, sales, import and export business of the broad drug Baiyunshan. At the beginning of this year, Guang medicine Baiyunshan announced the layout of high-end medical device research and development, the first phase of the production of pediatrics and orthopaedic professional MR machine-based. Whether it is a well-known domestic software companies or pharmaceutical giants or focused on the development of medical devices, enterprises have increased horsepower to develop high-end medical devices, hoping to get a piece of the market.to compete for the primary health care market
    domestic high-end medical device market to develop mainly benefit from policy support. According to relevant statistics, in 2015 alone, the country issued 18 relevant policies to support the development of domestic medical devices.
    Beijing Business Daily reporter to consult the relevant policy content learned that these policies mainly focus on procurement, research and development of production technology and so on. An important indicator of the market's ability to develop is undoubtedly whether products can be sold, and the above-mentioned policies facilitate the sale of domestic enterprises. At present, most domestic enterprises will be the main market in primary health care institutions.
    , according to Sanowisse President Fu Shinon, Sano wesheng developed CT mainly sales market divided between public and private medical institutions. Among them, the customer base of public hospitals is mainly secondary and below. Private hospitals, annual income of more than 100 million medical institutions rarely choose domestic CT, annual income in 50 million to 60 million yuan of hospitals are the layout of domestic CT focus.
    the grass-roots market has long become the focus of multinational medical device manufacturers layout, domestic brands will also face fierce competition. Back in 2009, GE Launched a Global Health Creation strategy, announcing a $3 billion investment over the next six years to develop 100 new products that increase medical coverage, improve quality and reduce costs.M;
    Beijing Dingchen Medical Management Consulting Center head Shi Lichen said that the medical device market mainly has three hospitals and primary medical institutions two major markets, primary medical institutions due to lack of funds and state-supported medical equipment replacement, domestic enterprises are easier to open this market.National technology is missing
    In the high-end medical equipment market more than 80% of the monopoly of multinational companies background, "localization" has been the main theme of recent policies and industries, "our hospital with nuclear magnetic resonance equipment and other medical equipment is mainly Siemens, the quality of domestic equipment still needs to be improved." Local enterprises can produce medical equipment, but the important part of the instrument domestic technology is still not. "A doctor at a sanjia hospital confessed.
    Fu Shinon introduced, the company produces CT product parts suppliers including overseas and domestic, mainly to mechanical processing and electronic processing, special materials processing, microelectronics processing and vacuum electronic processing mainly rely on foreign suppliers. In the procurement of spare parts accounted for a relatively large domestic, but the purchase amount abroad is higher, in more than 50%.
    , an unnamed analyst, told the Beijing Business Daily that some of the domestic technology does have independent research and development capabilities, but the more core components still can not break through, need to buy abroad, return home to assemble. But in this case after-sales damage repair becomes an indefinite bomb. Domestic high-end medical device market is now beginning to enter the development period, core technology and after-sales service is still the focus of medical institutions, but also domestic enterprises need to overcome the difficulties. (Beijing Business Daily)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.